Practice Areas
Tax Law
We provide tax advice and planning for companies and individuals on a wide range of federal tax issues
Employee Benefits & Compensation
We help companies to structure benefit programs and to comply with the laws governing compensation
Employment
We help executives negotiate their employment, equity compensation, and separation packages
Recent Posts
Protective Section 83(b) Elections
I am frequently asked whether a new tax code Section 83(b) election is necessary when vested stock is subjected to new vesting restrictions. This revesting most often occurs at a financing. The investors request the revesting to ensure that the founders stick around....
Compensating Employees with Tokens
So, your company has generated tokens, presumably offshore, and you want to use them to compensate employees. Common ways to do so include: Restricted Tokens Tokens can be sold or awarded directly to employees. Because the employee will either need to pay for the...
QSBS and Significant Redemptions
Qualified small business stock (“QSBS”) is a special type of stock that can result in 0% federal tax on the gain (up to a cap) from a sale if held more than 5 years. That is the good news. The bad news is that a company can accidentally disqualify otherwise eligible...
Using a Roth IRA to Fund Your Start-up
Updated. Originally posted May 13, 2022 Can I Use a Self-Directed Roth IRA to Fund My Start-Up? I was asked this question by three different clients yesterday. Ever since it was revealed that Peter Thiel reportedly accumulated billions of dollars inside his Roth IRA,...
QSBS Trust Stacking
May 2026 Update On May 20, 2026, Treasury Assistant Secretary for Tax Policy Kenneth Kies said during a conference in Washington, D.C., that the IRS is preparing guidance on the expanded exemption aimed at curbing what he described as stacking abuse. “Let me just warn...
Fixing Discount Stock Options
So, you accidentally granted one or more discount stock options. Now what? As quick background, a discount stock option has an exercise price below the fair market value of the underlying stock on the date of grant.[1] For whatever reason, Congress doesn’t like this...





